definiens: shall mean ( a ) all patent applications heretofore or hereafter filed or having legal force in any country within the Territory which are owned by or licensed to Immune Response or [COMPANY] ( other than licensed from the other party pursuant to the Agreement ) on the date of the Agreement or during the term of the Agreement, and which claim a Product, an Improvement or the process of manufacture or use of a Product in the applicable Field or otherwise are necessary or useful to make, use, develop, sell or seek regulatory approval in any country in the Territory to market a Product for use in the applicable Field ; ( b ) all patents that . have issued or in the future issue therefrom, including utility, model and design patents and cer - tificates of invention ; and ( c ) all divisionals, continuations, continuations - in - part, reissues, renewals, extensions or additions to any such patents and patent applications ; all to the extent and only to the extent that Immune Response or [COMPANY] now has or hereafter will have the right to grant licenses, immunities or other rights thereunder . Immune Response Patent Rights as they exist on the dates of Exhibit C, including updates thereto, are identified in Exhibit C which is attached hereto and incorporated herein . The parties intend that the first Exhibit C attached hereto include all Immune Response 's Patent Rights that exist at the time the parties enter into this agreement that are or · may be required for [COMPANY] 's practice of Product(s ) hereunder